ArticleInternational journal of clinical pediatric dentistry2025
Clinical Radiographic and Histological Evaluation of Zinc Bioactive Glass as a Pulpotomy Medicament in Primary Molar Teeth: An
Article in International journal of clinical pediatric dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the past 20 years, research into pulpotomy materials has transitioned into the "biological era," marked by the emergence of innovative dental materials such as bioactive glass, which are bio-inductive and supportive of regeneration. This evolution represents significant advancements in dentistry. Aim: To evaluate the clinical, radiographic, and histological success rate of zinc (Zn) bioactive glass as a pulpotomy medicament for primary molars. Patients and methods: A total sample size of 40 primary molars was selected from 36 children aged 6-9 years. A regular conventional pulpotomy procedure was followed by the placement of Zn bioactive glass over the radicular orifice. The pulp chamber was filled with reinforced zinc oxide eugenol (ZOE). Patient recall was scheduled at 3, 6, 9, and 12 months, respectively. Further evaluation was done by scanning electron microscopy (SEM). Data were tabulated and subjected to statistical analysis. Results: The present study shows 100, 97.44, 94.74, and 94.74% clinical success at the end of 3, 6, 9, and 12 months, respectively. The radiographic success was 100, 94.87, 92.11, and 92.11% at 3, 6, 9, and 12 months, respectively. SEM analysis showed a well-defined dentinal bridge formation between Zn bioactive glass and the pulp chamber. Conclusion: Quite promising clinical, radiographic, and histological results of Zn bioactive glass in the present study show its potential as an additional pulpotomy medicament to the presently existing pulpotomy agents. How to cite this article: Reddy VN, Reddy D, Snehitha K,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.